TCI Biotech to Unveil New Vision at Vitafoods Europe 2025: CDMO+, High-Absorption Innovation, and 45 Years of Scientific Leadership
Celebrating 45 Years of Impact
In celebration of its 45th anniversary, TCI is unveiling a bold new brand identity that reflects its core values: Let's Spark Whole Product Innovations. The rebranding signals a new chapter in TCI's legacy of accelerating innovation by leveraging bioresource data mining and proprietary R&D to fast-track product development.
Revolutionizing Nutrition Delivery with High-Absorption Liquid VMS
TCI will debut its latest innovations in liquid nutritional delivery, featuring patented technologies such as liposomal doubleNUTRI. These systems deliver unmatched bioavailability and shelf life in sleek, consumer-friendly formats.
Flagship offerings include:
- Liposomal doubleNUTRI: Enhances nutrient absorption in liquid formats; used in the S&B Exceed Skin Shot featuring MAXICollal collagen and Synergene for beauty and skin health.
- LipoTaste Omega-3: Delivers low-water active fish oil in a stable, palatable drink format for daily cardiovascular support.
- ActivPro™ Coating: Protects live probiotic strains in a chocolate gel matrix, ensuring stability and efficacy without refrigeration.
Each solution is tailored for immediate market readiness and optimized for current consumer trends.
Immersive Booth Experience and Thought Leadership
As a Platinum Conference Sponsor of the event, TCI Biotech's Dr.
Keynote Presentation
- Title: Healthy Gut, Healthy Life: Yesterday, Today, and Tomorrow
- Date:
May 21, 2025 - Time:
10:55 AM –11:25 AM - Location: Vitafoods Conference Theatre, FIRA Barcelona Gran Via
Exclusive Interview
- Title: Leveraging Nutrition to Optimise Microbiome Performance
- Date:
May 25, 2025 - Format: Published on Vitafoods Insights platform
Visitors to booth #3G6 will experience TCI's latest product breakthroughs firsthand, ranging from high-bioavailability liquid supplements and patented liposomal technologies to trend-driven prototypes across proteins, probiotics, herbal extracts, and VMF (Vitamins, Minerals, Fish Oil) solutions. Each display highlights TCI's formulation agility, global regulatory readiness, and commitment to fast-to-market innovation that empowers brands to lead in an evolving wellness landscape.
For more information, please visit https://www.tci-bio.com/.
About TCI Biotech
TCI Biotech (TCI Co., Ltd.) is a global leader in CDMO+ services, specializing in the research, development, and manufacturing of health foods and cosmetics. Committed to innovation and scientific excellence, TCI delivers high-quality, clinically backed products that empower customers worldwide.
View original content:https://www.prnewswire.com/news-releases/tci-biotech-to-unveil-new-vision-at-vitafoods-europe-2025-cdmo-high-absorption-innovation-and-45-years-of-scientific-leadership-302456781.html
SOURCE TCI; TCI Bio
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- New Study Data on Chemo-Immunotherapy Approach Using the ELIAS Cancer Immunotherapy (ECI®) to Treat Bone Cancer in Dogs Demonstrates Improved Outcomes
- Labviva Showcases Advanced AI Procurement Tools at the R&D Procurement and Sourcing in Pharma Summit 2025
- Ivanhoe Mines Announces Results of Voting for The Election of Directors
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
The Children's Investment Fund (TCI)Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!